oru.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Screening for celiac disease in the general population and in high-risk groups
Region Örebro län. Dept Paediat, Örebro University Hospital, Örebro, Sweden; Dept Med Epidemiol & Biostat, Karolinska Inst, Stockholm, Sweden.
Dept Epidemiol & Publ Hlth, Univ Nottingham, Nottingham, England.ORCID-id: 0000-0003-2555-2250
Sch Med, Univ Tampere, Tampere, Finland; Dept Internal Med, Tampere Univ Hosp, Tampere, Finland;Dept Internal Med, Seinajoki Cent Hosp, Seinajoki, Finland.
Dept Med, C Bonorino Udaondo Gastroenterol Hosp,Univ Salvador, Buenos Aires DF, Argentina.
Visa övriga samt affilieringar
2015 (Engelska)Ingår i: United European Gastroenterology journal, ISSN 2050-6406, E-ISSN 2050-6414, Vol. 3, nr 2, s. 106-120Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

Background: Celiac disease (CD) occurs in approximately 1% of the Western population. It is a lifelong disorder that is associated with impaired quality of life (QOL) and an excessive risk of comorbidity and death. Objectives: To review the literature on screening for CD in relation to the current World Health Organization (WHO) criteria for mass screening. Methods: We performed a PubMed search to identify indexed papers on CD screening with a publication date from 1900 until 1 June 2014. When we deemed an abstract relevant, we read the corresponding paper in detail. Results: CD fulfills several WHO criteria for mass screening (high prevalence, available treatment and difficult clinical detection), but it has not yet been established that treatment of asymptomatic CD may reduce the excessive risk of severe complications, leading to higher QOL nor that it is cost-effective. Conclusions: Current evidence is not sufficient to support mass screening for CD, but active case-finding may be appropriate, as we recognize that most patients with CD will still be missed by this strategy. Although proof of benefit is still lacking, screening for CD may be appropriate in high-risk groups.

Ort, förlag, år, upplaga, sidor
2015. Vol. 3, nr 2, s. 106-120
Nyckelord [en]
Celiac disease, gluten, gluten-free diet, review, screening, prevention, risk, quality of life, World Health Organization
Nationell ämneskategori
Gastroenterologi
Identifikatorer
URN: urn:nbn:se:oru:diva-56527DOI: 10.1177/2050640614561668ISI: 000352166700002PubMedID: 25922671OAI: oai:DiVA.org:oru-56527DiVA, id: diva2:1082658
Tillgänglig från: 2017-03-17 Skapad: 2017-03-17 Senast uppdaterad: 2018-07-08Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Ludvigsson, Jonas F.Card, Timothy R.Zingone, Fabiana
Av organisationen
Region Örebro län
I samma tidskrift
United European Gastroenterology journal
Gastroenterologi

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 217 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf